Item 9 Labs Corp. operates as a vertically integrated cannabis operator and dispensary franchisor in the United States. It operates through Cultivation, Franchising, and Corporate segments. The company produces cannabis and cannabis-related products in various categories, such as flower; concentrates; distillates; and hardware. It offers cannabis and cannabis-derived products and technologies through licensed dispensaries to consumers in Arizona. It also operates and sells medical and adult-use cannabis dispensary franchises under the Unity Rd brand name. Item 9 Labs Corp. is headquartered in Phoenix, Arizona.
Frequently asked questions
What sector does Item 9 Labs Corp (INLB) operate in?
Item 9 Labs Corp belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Item 9 Labs Corp (INLB) current stock price?
As of the latest data, Item 9 Labs Corp stock price is $0.00, with a previous close of $0.00.
What is Item 9 Labs Corp (INLB) current market capitalization?
Item 9 Labs Corp market cap is approximately 10.24 thousand.
What is Item 9 Labs Corp (INLB) Earnings Per Share (EPS)?
The trailing EPS is -$0.33.
Does Item 9 Labs Corp (INLB) pay dividends?
No. Item 9 Labs Corp does not pay a dividend.
What is Item 9 Labs Corp (INLB) beta (volatility) score?
Item 9 Labs Corp has a beta of 0.096, indicating lower volatility than the overall market.